Heart Failure Team had an exceptional year in 2024
Published: 9 January 2025
2024 was a bumper year for publications for the team
For the heart failure team, 2024 was a bumper year for publications. Together with colleagues around the World, the team contributed to over 300 original scientific papers, reviews, editorials, commentaries, position statements, guidelines and letters. Local, national, and global clinical trials and analyses of health service data resulted in many high-impact papers as shown in the Table. Hopefully, some of these new findings will change guidelines and clinical practice.
| Journal (IF) | Original Papers |
|---|---|
| Lancet (98.4) | 4 |
| NEJM (96.3) | 6 |
| BMJ (93.7) | 1 |
| JAMA (63.5) | 1 |
| Nature Medicine (58.7) | 2 |
| Lancet Diabetes (44.0) | 2 |
| Eur J Heart (38.1) | 10 |
| Circulation (35.6) | 15 |
| Lancet Public Health (25.4) | 1 |
| Lancet Planetary Health (25.2) | 1 |
| Lancet Digital Health (23.8) | 1 |
| J Am Coll Cardiol (21.7) | 28 |
| JAMA Neurol (20.9) | 1 |
| Lancet Global Health (20.0) | 1 |
| Eur J Heart Failure (16.9) | 51 |
| Lancet Rheumatology (15.0) | 1 |
| JAMA Cardiology (14.7) | 10 |
| Lancet Reg Heath Eur (13.6) | 1 |
| JACC: CardioOncology (13.6) | 2 |
| Lancet Healthy Longevity (13.4) | 1 |
| JACC-HF (10.3) | 23 |
*excluding reviews/editorials/position papers/consensus statements/guidelines/commentaries/letters
First published: 9 January 2025
<< News